Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma
Autor: | Victor Ho-Fun Lee, Hong Tang, Raymond Liu, Cailei Zhu, Ming Liu, Qiming Wang, Suxia Luo, Yongxu Jia, Juan Chen, Qian Yan, Lingxi Jiang, Yufeng Wu, Xin Yuan Guan, Yanru Qin |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine Cancer Research Esophageal Neoplasms L1 Down-Regulation Loss of Heterozygosity Biology Epigenesis Genetic Metastasis CHL1 Loss of heterozygosity 03 medical and health sciences 0302 clinical medicine Cell Line Tumor Genetics medicine Carcinoma Humans Neoplasm Invasiveness Neoplasm Metastasis Promoter Regions Genetic Molecular Biology Cell Proliferation Neoplasm Staging Cell growth Cell adhesion molecule Akt/PKB signaling pathway DNA Methylation medicine.disease Survival Analysis digestive system diseases Gene Expression Regulation Neoplastic 030104 developmental biology 030220 oncology & carcinogenesis Cancer research Female Esophageal Squamous Cell Carcinoma Cell Adhesion Molecules Signal Transduction |
Zdroj: | Oncogene. 38:3119-3133 |
ISSN: | 1476-5594 0950-9232 |
DOI: | 10.1038/s41388-018-0648-7 |
Popis: | Esophageal squamous cells carcinoma (ESCC) is a major common thoracic tumor characterized by distinctly high incidences and mortality rates. Despite advances in multimodality therapy, the mortality rate of ESCC remains high and understanding of molecular alterations leading to the development and progression of ESCC is still very limited. In this study, a new tumor suppressor candidate, cell adhesion molecule with homology to L1CAM (CHL1), located at 3p26 which was frequently deleted in ESCC was identified. Reduced expression of CHL1 correlated with poor differentiation, increased invasion, and lymph-node metastasis, advanced tumor stage, and decreased overall survival. Methylation-specific PCR and FISH assays revealed that down-regulation of CHL1 in both ESCC cell lines and clinical samples were associated with promoter hypermethylation and loss of heterozygosity. Functional studies using lentiviral-based overexpression and knockdown systems provided direct support of CHL1 to function as an important tumor suppressor with both anti-proliferation and anti-metastasis abilities, through Merlin and SEMA3B-Np1-mediated inhibition of AKT signaling pathway. Further characterization of CHL1 may provide a novel therapeutic target in ESCC treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |